ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Waxman To Speak At AACI Meeting

January 12, 1979

In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense

July 26, 1991

SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories

December 12, 1986

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

NCI to set separate payline for R01s over $700,000.

February 13, 2004